1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Application deadline was May 7, 2015; posted April 20, 2012; archived June 7, 2015. This is a decade-old closed opportunity.
Alzheimer's Disease Research Centers (P50) is sponsored by National Institute on Aging (NIA). The NIA invites applications from qualified institutions for support of Alzheimer's Disease Research Centers (ADRCs).
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
National Institute on Aging: Revision Requests for Active Alzheimer's Disease Centers (P50) - Federal Grant National Institute on Aging: Revision Requests for Active Alzheimer's Disease Centers (P50) The summary for the National Institute on Aging: Revision Requests for Active Alzheimer's Disease Centers (P50) grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants. com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact .
If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
National Institute on Aging: Revision Requests for Active Alzheimer's Disease Centers (P50): The National Institute on Aging invites Revision applications (formerly called competing supplements) to ongoing NIA-supported Alzheimer's Disease Centers (P50) in order to expand the scope of the existing award. Revision applications should include proposal of a new core or project.
Revision applications may not request support beyond the end date of the Parent P50 award.
National Institute on Aging: Revision Requests for Active Alzheimer's Disease Centers (P50) National Institutes of Health Funding Opportunity Number: Current Application Deadline: Original Application Deadline: Maximum Federal Grant Award: Minimum Federal Grant Award: Expected Number of Awards: Cost Sharing or Matching: Applicants Eligible for this Grant State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification) Additional Information on Eligibility Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
Grant Announcement Contact NIH OER [email protected] If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [ [email protected] ] Similar Government Grants • Artificial Intelligence and Technology Collaboratory (P30 Clinical Trial Optional) • Artificial Intelligence and Technology Collaboratory Coordinating Center (U24 Clinical Tri... • Claude D.
Pepper Older Americans Independence Centers (P30 Clinical Trial Optional) • NIA Expanding Research in AD/ADRD (ERA) Summer Research Education Program (R25 Independent... • NIA Expanding Research in AD/ADRD (ERA) Postbaccalaureate Research Education Program (R25 ... • Technological Enhancements and Archiving for Surveys of the Elderly: SBIR (R43/44) Initiat...
• Technological Enhancements and Archiving for Surveys of the Elderly: STTR (R41/42) Initiat... • Technology and Aging: NIA Small Business Technology Transfer Program Initiative (STTR [R41...
More Grants from the National Institutes of Health • NIH Science Education Partnership Award (SEPA) (R25 - Clinical Trial Not Allowed) • Tuberculosis Research Advancement Centers (TRACs) (P30 Clinical Trial Not Allowed) • Coccidioidomycosis Collaborative Research Centers (P01 Clinical Trial Not Allowed) • Discovery of in vivo Chemical Probes for the Nervous System (R01 Clinical Trial Not Allowe...
• Bioengineering Research Grants (BRG) (R01 Clinical Trial Optional) Federal Grants by Category Grants for Single Mothers Small Business Grants for Women Federal Grants for College Federal Tuition Assistance
According to the current listing, eligibility includes: Public and State controlled institutions of higher education; Private institutions of higher education; Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education; Other Eligible Appl…. Confirm the full requirements in the official notice before applying.
The current listing shows $1,000,000 (ceiling for previous iteration). Verify award ceilings, matching requirements, and allowable costs in the official notice.
Alzheimer's Disease Research Centers (P50) is funded by National Institute on Aging (NIA). Verify program details on the funder's official page before applying.
Yes — this listing is flagged as national in scope, so applicants across the U.S. may apply, subject to the sponsor's other eligibility criteria.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Small Business Technology Transfer (STTR) Program is sponsored by National Institute on Aging (NIA), National Institutes of Health (NIH). The NIA STTR program encourages small businesses to collaborate formally with research institutions to develop and commercialize innovative treatments or technologies to help people enjoy healthier lives as they age, including solutions for Alzheimer's disease and related dementias. This program supports feasibility studies to later stage research and development (R&D) needed to develop a commercial product.
NIA Small Business Programs (SBIR & STTR) is sponsored by National Institute on Aging - NIH. The NIA Small Business Programs manage the largest source of early-stage funding for aging-related research and development (R&D). They provide grants to small businesses through the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs to develop innovative technologies that enhance the health and well-being of older adults, including digital health and sensing technologies that address factors impacting the aging population, Alzheimer's disease, and related dementias. This includes technologies that promote aging in place and reduce caregiving burden.
The National Institute on Aging's FY 2026 AD/ADRD portfolio consolidates the dementia research infrastructure layer — NCRAD, NACC, the new AI and Technology Collaboratory Coordinating Center — into a small number of large, often single-source cooperative agreements. The $113M new-research increment goes elsewhere. For investigators submitting in FY 2026, the structural change matters more than the headline dollar number.
Read articleSeven research teams will run the first clinical trials aimed at extending human healthspan under ARPA-H PROSPR contracts worth up to $144M. The milestone-based contract model breaks every convention of federal biomedical funding.
Read articleARPA-H PROSPR program funds seven research teams up to $144M to develop the first clinical trials targeting biological aging itself, testing rapamycin analogs, semaglutide, and retrotransposon inhibitors.
Read article